Evidence map›Paper›PMID 25017067›Full record

ArticleCell reports2014

The strength of an Ig switch region is determined by its ability to drive R loop formation and its number of WGCW sites.

Zheng Z Zhang, Nicholas R Pannunzio, Li Han, Chih-Lin Hsieh, Kefei Yu, Michael R Lieber

Abstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Current insights into the mechanism of mammalian immunoglobulin class switch recombination.Critical reviews in biochemistry and molecular biology · 2019
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. AID hits the jackpot when missing the target.Current opinion in immunology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zheng Z ZhangUSC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA; Molecular and Computational Biology Section, Department of Biological Sciences, USC Dornsife, University of Southern California, Los Angeles, CA 90033, USA; Departments of Pathology, Biochemistry & Molecular Biology, Molecular Microbiology & Immunology, and Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Nicholas R PannunzioUSC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA; Molecular and Computational Biology Section, Department of Biological Sciences, USC Dornsife, University of Southern California, Los Angeles, CA 90033, USA; Departments of Pathology, Biochemistry & Molecular Biology, Molecular Microbiology & Immunology, and Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Li HanDepartment of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA.
Chih-Lin HsiehUSC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA; Molecular and Computational Biology Section, Department of Biological Sciences, USC Dornsife, University of Southern California, Los Angeles, CA 90033, USA; Departments of Pathology, Biochemistry & Molecular Biology, Molecular Microbiology & Immunology, and Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Kefei YuDepartment of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA. Electronic address: yuke@msu.edu.
Michael R LieberUSC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA; Molecular and Computational Biology Section, Department of Biological Sciences, USC Dornsife, University of Southern California, Los Angeles, CA 90033, USA; Departments of Pathology, Biochemistry & Molecular Biology, Molecular Microbiology & Immunology, and Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. Electronic address: lieber@usc.edu.

Funding

MECHANISM AND REGULATION OF NONHOMOLOGOUS DNA ENDJOININGR01CA100504 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIEBER, MICHAEL R · 2003 to 2021
$5.0M
Mechanism of R-loop Formation in CSR and SHMR01GM056984 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIEBER, MICHAEL R · 1998 to 2015
$2.7M
HUMAN VDJ RECOMBINASE IN NEOPLASTIC AND PRIMARY CELLSR01CA051105 · NCI · WASHINGTON UNIVERSITY · PI LIEBER, MICHAEL R · 1990 to 2004
$1.6M
NCI NIH HHS R01 CA051105NCI NIH HHS R01 CA100504NIGMS NIH HHS R01 GM056984
6 · The paper itself

Abstract

R loops exist at the murine IgH switch regions and possibly other locations, but their functional importance is unclear. In biochemical systems, R loop initiation requires DNA sequence regions containing clusters of G nucleotides, but cellular studies have not been done. Here, we vary the G-clustering, total switch region length, and the number of target sites (WGCW sites for the activation-induced deaminase) at synthetic switch regions in a murine B cell line to determine the effect on class switch recombination (CSR). G-clusters increase CSR regardless of their immediate proximity to the WGCW sites. This increase is accompanied by an increase in R loop formation. CSR efficiency correlates better with the absolute number of WGCW sites in the switch region rather than the total switch region length or density of WGCW sites. Thus, the overall strength of the switch region depends on G-clusters, which initiate R loop formation, and on the number of WGCW sites.

Indexed as

Immunoglobulin Class SwitchingImmunoglobulin Switch RegionAnimalsB-LymphocytesCell Line, TumorGC Rich SequenceMiceNucleic Acid Conformation

Identifiers

PMID25017067
PMCPMC4118936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.